Page last updated: 2024-08-17

2-naphthylamine and Idiopathic Parkinson Disease

2-naphthylamine has been researched along with Idiopathic Parkinson Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fink, AL; Li, J; Zhu, M1
Dijkstra, D; Johnson, SJ; Meltzer, LT; Pugsley, TA; Rodenhuis, N; Sundell, S; Venhuis, BJ; Wikström, HV; Wise, LD; Wustrow, D1

Other Studies

2 other study(ies) available for 2-naphthylamine and Idiopathic Parkinson Disease

ArticleYear
The association of alpha-synuclein with membranes affects bilayer structure, stability, and fibril formation.
    The Journal of biological chemistry, 2003, Oct-10, Volume: 278, Issue:41

    Topics: 2-Naphthylamine; alpha-Synuclein; Fluorescent Dyes; Humans; In Vitro Techniques; Kinetics; Laurates; Lipid Bilayers; Microscopy, Atomic Force; Molecular Structure; Nerve Tissue Proteins; Parkinson Disease; Protein Binding; Protein Conformation; Protein Structure, Secondary; Recombinant Proteins; Spectrometry, Fluorescence; Synucleins

2003
A new type of prodrug of catecholamines: an opportunity to improve the treatment of Parkinson's disease.
    Journal of medicinal chemistry, 2002, Jun-06, Volume: 45, Issue:12

    Topics: 2-Naphthylamine; Administration, Oral; Animals; Antiparkinson Agents; Catecholamines; Crystallography, X-Ray; Male; Microdialysis; Molecular Conformation; Parkinson Disease; Prodrugs; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; Stereoisomerism; Structure-Activity Relationship; Tetrahydronaphthalenes

2002